|
Affiliation |
Faculty of Medicine College Hospital Cancer diagnosis and treatment part |
|
Title |
Assistant Professor |
|
External Link |
|
SUETA Mitsue
|
|
|
Papers 【 display / non-display 】
-
Loss of Tyrosine Kinase 2 Does Not Affect the Severity of <i>Jak2</i>V617F-induced Murine Myeloproliferative Neoplasm. Reviewed
Yamaji T, Shide K, Kameda T, Sekine M, Kamiunten A, Hidaka T, Kubuki Y, Shimoda H, Abe H, Miike T, Iwakiri H, Tahara Y, Sueta M, Yamamoto S, Hasuike S, Nagata K, Shimoda K
Anticancer research 37 ( 7 ) 3841 - 3847 2017.7
Language：English Publishing type：Research paper (scientific journal)
-
Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations. Reviewed
Kubuki Y, Shide K, Kameda T, Yamaji T, Sekine M, Kamiunten A, Akizuki K, Shimoda H, Tahira Y, Nakamura K, Abe H, Miike T, Iwakiri H, Tahara Y, Sueta M, Hashimoto K, Yamamoto S, Hasuike S, Hidaka T, Nagata K, Kitanaka A, Shimoda K
Annals of laboratory medicine 37 ( 2 ) 159 - 161 2017.3
Language：English Publishing type：Research paper (scientific journal)
-
TET2 mutation in diffuse large B-cell lymphoma. Reviewed
Kubuki Y, Yamaji T, Hidaka T, Kameda T, Shide K, Sekine M, Kamiunten A, Akizuki K, Shimoda H, Tahira Y, Nakamura K, Abe H, Miike T, Iwakiri H, Tahara Y, Sueta M, Yamamoto S, Hasuike S, Nagata K, Kitanaka A, Shimoda K
Journal of clinical and experimental hematopathology 56 ( 3 ) 145 - 149 2017
Language：English Publishing type：Research paper (scientific journal) Publisher：日本リンパ網内系学会
<i>Ten-eleven translocation-2 (TET2)</i> mutation is frequently observed in myeloid malignancies, and loss-of-function of TET2 is essential for the initiation of malignant hematopoiesis. <i>TET2</i> mutation presents across disease entities and was reported in lymphoid malignancies. We investigated <i>TET2</i> mutations in 27 diffuse large B-cell lymphoma (DLBCL) patients and found a frameshift mutation in 1 case (3.7%). <i>TET2</i> mutation occurred in some populations of DLBCL patients and was likely involved in the pathogenesis of their malignancies.
DOI： 10.3960/jslrt.56.145
-
Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator.
Kameda T, Shide K, Yamaji T, Kamiunten A, Sekine M, Taniguchi Y, Hidaka T, Kubuki Y, Shimoda H, Marutsuka K, Sashida G, Aoyama K, Yoshimitsu M, Harada T, Abe H, Miike T, Iwakiri H, Tahara Y, Sueta M, Yamamoto S, Hasuike S, Nagata K, Iwama A, Kitanaka A, Shimoda K
Blood 125 ( 2 ) 304 - 15 2015.1
Language：Japanese Publishing type：Research paper (scientific journal)